Business Context and Reporting Period
Palisade Bio, Inc. (PALI) filed a Form 8-K on April 29, 2025, reporting a notice received from The Nasdaq Stock Market LLC regarding its continued listing status. The company is incorporated in Delaware and trades on the Nasdaq Capital Market.
Key Financial Metrics
This filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stock price.
Material Changes
The material event reported is a deficiency in the Minimum Bid Price Requirement. Nasdaq notified the company that for 30 consecutive trading days preceding the notice, the closing bid price of its common stock was below the required $1.00 per share threshold under Nasdaq Listing Rule 5550(a)(2).
Outlook, Risks, and Management Commentary
- Compliance Period: The company has 180 calendar days from the date of the notice to regain compliance. Compliance is achieved if the closing bid price is at least $1.00 for a minimum of 10 consecutive business days.
- Additional Compliance Period: If the company fails to regain compliance within the initial 180 days, it may be granted an additional 180-day period, provided it meets other listing standards (such as market value of publicly held shares) and demonstrates intent to cure the deficiency.
- Delisting Risk: Failure to regain compliance by the end of the Compliance Period or Additional Compliance Period will result in the delisting of the company's common stock.
- Management Action: Management intends to monitor the stock price and may consider implementing available options to regain compliance.
Investor Verification Checklist
- Verify the current closing bid price of PALI stock to assess proximity to the $1.00 threshold.
- Monitor the company's stock price for 10 consecutive business days to determine if the initial compliance requirement is met.
- Review future filings for announcements regarding reverse stock splits or other capital structure changes intended to address the price deficiency.
- Check the company's market value of publicly held shares to ensure eligibility for the Additional Compliance Period if the initial period expires without compliance.